| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6cb4ab729c5c94a203059e5d3f32dbeb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8287b8d98637425602d348d68934b66d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_78e6f025e333bf49adc475e70569c7bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8c55099f038b69a4a093b0d23bec4db3 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00 |
| filingDate |
2004-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2beafa963c7f866143816056037fffba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a93765d3678ab5250a04a891c754b874
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf4668186e7d6a709c0254f74df51a22 |
| publicationDate |
2004-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2004084916-A1 |
| titleOfInvention |
Use of acetyl-d-aminoglycosamine in treatment of local lesions and systematic symptoms related to infections of virus or bacteria |
| abstract |
The invention relates to the use of N-acetyl-D-aminoglycosamine and a pharmaceutically acceptable salt thereof in preparation of drugs for treatment of local lesions and systematic symptoms related to infections of virus or bacteria. N-acetyl-D-aminoglycosamine or a pharmaceutically acceptable salt thereof as an active ingredient in parentenal formulations is used in treatment of systematic symptom of toxicosis related to infections of virus or bacteria, or local and systematic lesions related to endotoxin or exotoxin, with a efficient rate of 90%. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114732822-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114732822-B |
| priorityDate |
2003-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |